ALDX - Aldeyra Therapeutics, Inc.
1.57
-0.010 -0.637%
Share volume: 724,956
Last Updated: 04-28-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$1.58
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 11-07-2024 | 02-28-2025 | 05-14-2025 | 08-07-2025 | 11-05-2025 | 02-27-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 9.394 M | 18.008 M | 16.138 M | 16.578 M | 10.427 M | 10.169 M | 8.001 M | 6.668 M | |
| Selling general and admin | 3.210 M | 3.038 M | 3.696 M | 1.948 M | 3.004 M | 1.664 M | 2.570 M | 2.364 M | |
| Research and development | 6.184 M | 14.970 M | 12.442 M | 14.630 M | 7.423 M | 8.505 M | 5.431 M | 4.304 M | |
| Total expenses | 9.394 M | 18.008 M | 16.138 M | 16.578 M | 10.427 M | 10.169 M | 8.001 M | 6.668 M | |
| 91.70% | -10.39% | 2.73% | -37.10% | -2.48% | -21.32% | -16.66% | |||
| Operating income | -9.394 M | -18.008 M | -16.138 M | -16.578 M | -10.427 M | -10.169 M | -8.001 M | -6.668 M | |
| Ebit | -9.394 M | -18.008 M | -16.138 M | -16.578 M | -10.427 M | -10.169 M | -8.001 M | -6.668 M | |
| Pretax income | -8.082 M | -16.848 M | -15.113 M | -15.809 M | -9.930 M | -9.767 M | -7.688 M | -6.462 M | |
| 108.45% | -10.30% | 4.60% | -37.19% | -1.63% | -21.28% | -15.96% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -8.082 M | -16.848 M | -15.113 M | -15.809 M | -9.930 M | -9.767 M | -7.688 M | -6.462 M | |
| -108.45% | 10.30% | -4.60% | 37.19% | 1.63% | 21.28% | 15.96% |